Articles

According to a new long-term study, diabetic patients with even mild coronary artery disease face the same relative risk for a heart attack or other major adverse heart events as diabetics with...

CT-FFR, FFR-CT

The U.S. Food and Drug Administration (FDA) today cleared HeartFlow’s FFR-CT (fractional flow reserve—computed tomography) software, which permits non-invasive evaluation of coronary artery blood...

AHA, warfarin, antiplatelet therapy, atrial fibrillation, anti-clotting, EP lab

Long-term overtreatment with the anti-clotting drug warfarin combined with antiplatelet therapy to prevent stroke may raise the risk of dementia in people with atrial fibrillation.

3-D heart model, congenital heart defects, cardiovascular surgery

An experimental 3-D printed model of the heart may help surgeons treat patients born with complicated heart disorders, according to research presented at the American Heart Association’s...

DAPT study

Patients who took dual antiplatelet therapy medications beyond the standard 12 months after coronary stent placement were significantly less likely to develop blood clots within their stents or to...

VIVA, VIVA Physicians, Peripheral, Carotid Artery Device, clinical trial results

Viva Physicians, a not-for-profit organization in the field of vascular medicine and intervention, announce clinical trial results and other new happenings at Viva '14, hosted in Las Vegas,...

Shockwave, lithoplasty, lithotripsy

Shockwave Medical announced positive clinical results from Disrupt PAD, a single-arm multicenter study evaluating the safety and utility of Lithoplasty balloon catheters for the treatment of...

For the treatment of peripheral artery disease in leg arteries above the knee, the IN.PACT Admiral ...

McKesson Cardiology, cardiac PACS, CVIS

For any cardiology department looking to upgrade or replace its cardiovascular picture archiving and communications system (cardiac PACS), or cardiovascular information system (CVIS), the main...